Editorial ArticleDrug Discovery & Development
Modeling immune related adverse events in preclinical research
In this guest editorial, Dr. Courtney Noah, BioIVT's Vice President of Scientific Affairs, explores why disease state donors and purified immune subsets improve predictive safety models
